Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Revenue of Invitae Corporation (NVTA)
Revenue in 2022 (TTM): $516.3 M
According to Invitae Corporation's latest financial reports the company's current revenue (TTM) is $516.3 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Invitae Corporation
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2022 | $516.3 M | $99.05 M | $-3,118,410,000 | $-3,151,197,000 | $-3,106,293,000 |
| 2021 | $460.45 M | $111.78 M | $-391,641,000 | $-415,863,000 | $-379,006,000 |
| 2020 | $279.6 M | $81.32 M | $-652,172,000 | $-714,270,000 | $-608,870,000 |
| 2019 | $216.82 M | $98.72 M | $-244,112,000 | $-260,415,000 | $-241,965,000 |
| 2018 | $147.7 M | $67.59 M | $-111,585,000 | $-132,155,000 | $-129,355,000 |
| 2017 | $68.22 M | $18.08 M | $-121,582,000 | $-125,236,000 | $-123,380,000 |
| 2016 | $25.05 M | $-2,830,000 | $-93,630,000 | $-100,256,000 | $-100,256,000 |
| 2015 | $8.38 M | $-8,145,000 | $-89,477,000 | $-89,782,000 | $-89,782,000 |
| 2014 | $1.6 M | $-4,020,000 | $-45,189,000 | $-47,668,000 | $-47,668,000 |
| 2013 | $148 K | $-519,000 | $-23,851,000 | $-24,838,000 | $-24,838,000 |
| 2012 | $ | $ | $-8,282,000 | $-8,602,000 | $-8,602,000 |